Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 22, 2016

View Archived Issues

Ionis, AstraZeneca move antisense drug for cardiovascular disease into preclinical studies

Medix seeks Mexican clearance to begin phase III study of tesofensine for obesity

Galapagos reports topline results from phase II study of potentiator GLPG-1837 in cystic fibrosis

NIH awards grant to Albert Einstein College of Medicine

MaxCyte and Washington University form immuno-oncology collaboration

Phase I data for novel anti-CD22 CAR therapy in pediatric and young adult patients with ALL

DiaMedica reports positive results from phase I study of KLK1 product

PvP Biologics advancing treatment for celiac disease

Novartis to acquire Encore Vision

PsiOxus Therapeutics and BMS sign exclusive worldwide license agreement for NG-348

Preliminary phase I data for Viralym-C in patients with refractory CMV infection

Positive topline data presented from phase IIb BRID study of biphasic remogliflozin

Genetic modeling and therapeutic targeting of ETV6-NTRK3 fusion in ALL

HMGA1 polymorphism protects against proliferative diabetic retinopathy

Marketing authorization for Zebinix extended

Neos Therapeutics resubmits NDA for Cotempla XR-ODT

I-MAB granted rights to Ferring's olamkicept

Merrimack announces discontinuation of phase II HERMIONE trial of MM-302

Astellas' acquisition of Ganymed Pharmaceuticals now complete

NanoCarrier discontinues phase I trial of NC-6004 for head and neck cancer

FDA issues complete response letter regarding Lutathera

Actelion in exclusive negotiations with Johnson & Johnson

Inovio Pharmaceuticals reports positive results from first human study of Zika vaccine

Phase III study of emicizumab prophylaxis in hemophilia A meets primary endpoint

Merck & Co. and SD R&D patent PDE2 inhibitors

Merck & Co. discloses BTK inhibitors

Orion describes alpha2C-adrenoceptor antagonists

Chinese scientists develop CDK/cyclin inhibitors

Antiviral drug ribavirin shows promise as new therapeutic option for glioblastoma

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...